Coegin Pharma (NGM:COEGIN) Buyback Yield %: -8.03 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:COEGIN Coegin Pharma NGM:COEGIN
30 GF Score
Price kr3.33
! 2 Warning Signs
View Full Analysis

What is Coegin Pharma Buyback Yield %?

Coegin Pharma NGM:COEGIN -0.89% 30 Buyback Yield % is -8.03 as of Jul. 16, 2026. GuruFocus rates NGM:COEGIN with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 740 Biotechnology companies, Coegin Pharma ranks better than 52.16% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Coegin Pharma's current buyback yield was -8.03%.

Coegin Pharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Coegin Pharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coegin Pharma Buyback Yield % Chart

Coegin Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only -0.16 0.00 -59.60 -47.01 0.00

Coegin Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.19 -22.42 -8.80 0.00 -6.81

NGM:COEGIN vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Coegin Pharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coegin Pharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coegin Pharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Coegin Pharma's Buyback Yield % falls into.


NGM:COEGIN
30GF Score
Coegin Pharma NGM:COEGIN
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coegin Pharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Coegin Pharma's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 110.45832
=0.00%

Coegin Pharma's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 7) / 111.21899
=-6.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -8.03 mean?
Coegin Pharma (NGM:COEGIN) has a Buyback Yield % of -8.03 as of Jul. 16, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Coegin Pharma and its competitors. According to the industry distribution chart, Coegin Pharma ranks #354 out of 740 companies in the Biotechnology industry, placing it in the top 47.8%.
Is Coegin Pharma's Buyback Yield % too high?
Coegin Pharma's current Buyback Yield % is -8.03. Based on the distribution chart, Coegin Pharma ranks #354 out of 740 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Coegin Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Coegin Pharma's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Coegin Pharma ranks #354 out of 740 companies for Buyback Yield %. This puts Coegin Pharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Coegin Pharma and its competitors. Coegin Pharma's current Buyback Yield % is -8.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coegin Pharma stock overvalued right now?
Coegin Pharma (NGM:COEGIN) has a current Buyback Yield % of -8.03. The current Buyback Yield % is -8.03. Coegin Pharma's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Coegin Pharma (NGM:COEGIN), the current Buyback Yield % is -8.03 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coegin Pharma Business Description

Other Exchanges 7Z6:Germany
Address c/o Medicon Village, Lund, SWE, 223 81
Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.
30GF Score

Get the complete analysis for NGM:COEGIN

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.33
Price